semaglutide and metformin Frontiers oral semaglutide vs metformin A

In summer 2022, Lilly released tirzepatides spectacular Phase III trial results that showed a category-leading 22% weight loss with low side effect burden

Ann Pharmacotherapy (2016) 40(10):177784

The SURPASS-2 trial provided a head-to-head comparison between tirzepatide and semaglutide in patients with type 2 diabetes

Are GLP-1 receptor agonists associated with an increased risk of depression and anxiety

The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome

Frenzel, R., Voigt, C